Scientists of the KIT and the University of Kiev have produced an antibiotic, whose biological activity can be controlled with light.
Thanks to the robust diarylethene photoswitch, the antimicrobial effect of the peptide mimetic can be applied in a spatially and temporally specific manner. This might open up new options for the treatment of local infections, as side effects are reduced. The researchers present their photoactivable antibiotic with the new photomodule in a “Very Important Paper” of the journal “Angewandte Chemie”.
Photoswitchable molecules modify their structure and properties when exposed to light of an adequate wavelength. Among the photoswitches known are diarylethenes. By reversible photoisomerization, i.e. a reversible light-induced internal relocation of the molecule, the open form is turned into a closed form. Such photoswitch-able molecules are applied in molecular electronics and many other areas. Particularly interesting opportunities result from the insertion of photoswitches into biomolecules to control their activity by light. Interest focuses on so-called peptide mimetics, compounds whose major structural elements emulate a peptide, i.e. a small protein.
For the first time now, a group of researchers headed by Professor Anne S. Ulrich, Director of the Institute for Biological Interfaces 2 (IBG2) and holder of the Chair for Biochemistry at the Institute of Organic Chemistry (IOC) of KIT, has produced a photoswitchable peptide mimetic based on a diarylethene scaffold that can be photoisomerized reversibly. The scientists modified this building block into an amino acid analog and incorporated it directly into the backbone of the annular peptide antibiotic Gramicidin S. Biological activity of the resulting peptide mimetic can be controlled spatially and temporally with the help of UV and visible light. To demonstrate this, the scientists treated a bacterial film with the inactivated antibiotic and exposed it to light via a mask. As a result, the photoswitchable diarylethene was converted from a closed into an open form. Due to the structural modification induced, the entire substance molecule had a much higher antimicrobial effect. “In the future, such photoactivable antibiotics might be used as smart therapeutic agents against local bacterial infections,” Professor Anne S. Ulrich explains. “Usual side effects can also be minimized by switching.” Based on this strategy, new peptide-based agents against cancer might be feasible, as the newly developed photoactivable building block can also be applied in other peptide sequences.
The Latest on: Antibiotic
via Google News
The Latest on: Antibiotic
- Antibiotic-Resistant Bacteria Emerging in Community Settingson August 4, 2022 at 11:28 am
CREs are a group of multidrug-resistant bacteria considered an urgent health threat by the CDC because they can rapidly spread between patients, especially those who are most seriously ill and ...
- Early-life acquisition of antimicrobial resistance in newborn children from low- and middle-income countrieson August 4, 2022 at 8:12 am
Sepsis is a primary cause of mortality in newborns, particularly in low- and middle-income countries (LMICs). A new study coordinated by Professor Tim Walsh at the Ineos Oxford Institute for ...
- Teixobactin’s two pronged antibiotic attack mechanism revealedon August 4, 2022 at 7:16 am
The precise way in which teixobactin, the first promising new antibiotic in decades, kills bacteria has been unravelled. This discovery will help pave the way for further optimisation of this compound ...
- Utrecht University: ‘Youngest’ antibiotic kills bacteria via a new two-step mechanismon August 4, 2022 at 2:04 am
Scientists at Utrecht University have discovered a new mechanism of how antibiotics kill bacteria. The antibiotic teixobactin uses a dual molecular strategy: it blocks the bacterial cell wall ...
- 'Youngest' antibiotic kills bacteria via a new two-step mechanismon August 3, 2022 at 8:00 am
Scientists at Utrecht University have discovered a new mechanism antibiotics use to kill bacteria. The antibiotic teixobactin uses a dual molecular strategy: it blocks the bacterial cell wall ...
- Antibiotic API Market In 2022 : Research Insights with Upcoming Trends, Opportunities, Competitive Analysis, Forecast to 2022-2028on August 2, 2022 at 6:52 pm
Aug 02, 2022 (The Expresswire) -- "Antibiotic API Market" Insights 2022 By Types, Applications, Regions and Forecast to 2028. The global Antibiotic ...
- Taking This Common Antibiotic After Sex Might Help Prevent STDson August 1, 2022 at 9:42 am
A new study claims a common antibiotic can help prevent STDs, which have been on the rise following the pandemic.
- Single Dose Of Antibiotic Can Prevent Syphilis, Gonorrhoea And Other STDson July 30, 2022 at 8:40 am
In a new study it was revealed that if a person administers a single dose of a widely used, cheap antibiotic within 3 days of unprotected sexual intercourse, then it can help prevent the three types ...
- Antibiotic exposure in early childhood linked to later development of asthma and allergieson July 28, 2022 at 10:56 am
Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.
- Antibiotic taken after sex drastically reduces STDs: studyon July 27, 2022 at 12:54 pm
An antibiotic taken after sex without a condom can drastically reduce the rate of three bacterial STDs among high-risk groups, data from a clinical study showed Wednesday.
via Bing News